Pasithea Therapeutics Corp.
KTTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001841330
No open-market purchases or sales by Pasithea Therapeutics Corp. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $8.66M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Pasithea Therapeutics Corp. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 7 | 6 | −1 |
| Shares | 30.0K | 9.09K | −20.9K (−69.7%) |
| Value | $151.6K | $48.9K | −$102.7K (−67.7%) |
New holders (1)
Institutions that held Pasithea Therapeutics Corp. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 1,500 | $8.13K | 0.00% |
Sold out (2)
Institutions that held Pasithea Therapeutics Corp. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| ADAR1 Capital Management, LLC | 27,696 | $140.2K |
| FMR LLC | 49 | $256 |